Medical University of Lublin
Doctorat / PhD Profil chercheur : First Stage Researcher (R1) Type de contrat : Temporary Date limite de candidature : 13 Nov 2026 - 23:59 (Europe/Warsaw) Programme UE : Not funded by a EU programme Département : Department of Biopharmacy Domaine : Biological sciences » Biology
We seek a highly motivated and enthusiastic PhD student at the Department of Biopharmacy, Chair of Chemistry, Medical University of Lublin . The position is part of the OPUS 29 project “Drug Discovery and Development to Target Human Diseases-associated SLC35F Solute Carriers” , financed by the NCN (National Science Centre, Poland), grant agreement no. UMO-2025/57/B/NZ1/02424. Principal Investigator of the project (PI): dr hab. Sven Stefan, university professor ABOUT A PROJECT https://www.ncn.gov.pl/sites/default/files/listy-rankingowe/2025-03-17-mmatyB0da2/streszczenia/647603-en.pdf WORK TASKS Application of established synthesis schemes to derivatize known drugs and drug candidates Development and application of new synthesis schemes to derivatize hit molecules / experimental compounds. Purification ( e.g. , chromatography) and instrumental characterization ( e.g. , spectroscopy and spectrometry) of newly synthesized compounds. Application of newly established functional assays and high-throughput-suitable compound assessment platform to determine bioactivity of newly synthesized compounds. Application of computational models to predict new bioactive compounds / new chemotypes. Documentation of organic synthesis and instrumental analytics procedures. Data acquisition, assay read-out interpretation including statistical methods, data collection, data processing, data curation, and data storage under consideration of FAIR principles and the data management plan. Communication of research results internally and externally on national and international conferences.
We seek a highly motivated and enthusiastic PhD student at the Department of Biopharmacy, Chair of Chemistry, Medical University of Lublin . The position is part of the OPUS 29 project “Drug Discovery and Development to Target Human Diseases-associated SLC35F Solute Carriers” , financed by the NCN (National Science Centre, Poland), grant agreement no. UMO-2025/57/B/NZ1/02424.
Principal Investigator of the project (PI): dr hab. Sven Stefan, university professor
ABOUT A PROJECT
https://www.ncn.gov.pl/sites/default/files/listy-rankingowe/2025-03-17-mmatyB0da2/streszczenia/647603-en.pdf
WORK TASKS
Application of established synthesis schemes to derivatize known drugs and drug candidates
Development and application of new synthesis schemes to derivatize hit molecules / experimental compounds.
Purification ( e.g. , chromatography) and instrumental characterization ( e.g. , spectroscopy and spectrometry) of newly synthesized compounds.
Application of newly established functional assays and high-throughput-suitable compound assessment platform to determine bioactivity of newly synthesized compounds.
Application of computational models to predict new bioactive compounds / new chemotypes.
Documentation of organic synthesis and instrumental analytics procedures.
Data acquisition, assay read-out interpretation including statistical methods, data collection, data processing, data curation, and data storage under consideration of FAIR principles and the data management plan.
Communication of research results internally and externally on national and international conferences.
Where to apply E-mail [email]
Talnivo calcule votre score de compatibilité CV ↔ offre et vous aide à l'améliorer avant de postuler.
Créer un compte gratuitVoir toutes les offres sur Talnivo